nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.0126	0.0381	CbGeAlD
Quazepam—GABRD—forebrain—attention deficit hyperactivity disorder	0.011	0.0331	CbGeAlD
Quazepam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.0106	0.0319	CbGeAlD
Quazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.0102	0.0308	CbGeAlD
Quazepam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00822	0.0248	CbGeAlD
Quazepam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00774	0.0234	CbGeAlD
Quazepam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00725	0.0219	CbGeAlD
Quazepam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.0072	0.0217	CbGeAlD
Quazepam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00713	0.0215	CbGeAlD
Quazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00707	0.0213	CbGeAlD
Quazepam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00698	0.0211	CbGeAlD
Quazepam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00693	0.0209	CbGeAlD
Quazepam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00686	0.0207	CbGeAlD
Quazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00683	0.0206	CbGeAlD
Quazepam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00677	0.0204	CbGeAlD
Quazepam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.00671	0.0202	CbGeAlD
Quazepam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.0066	0.0199	CbGeAlD
Quazepam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.00613	0.195	CrCbGaD
Quazepam—GABRD—nervous system—attention deficit hyperactivity disorder	0.00596	0.018	CbGeAlD
Quazepam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00594	0.0179	CbGeAlD
Quazepam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.00574	0.0173	CbGeAlD
Quazepam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.00574	0.0173	CbGeAlD
Quazepam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.00561	0.0169	CbGeAlD
Quazepam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.00556	0.0168	CbGeAlD
Quazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00553	0.0167	CbGeAlD
Quazepam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.00552	0.0167	CbGeAlD
Quazepam—GABRG3—brain—attention deficit hyperactivity disorder	0.0055	0.0166	CbGeAlD
Quazepam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.00541	0.172	CrCbGaD
Quazepam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.0054	0.172	CrCbGaD
Quazepam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.0054	0.0163	CbGeAlD
Quazepam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.00536	0.0162	CbGeAlD
Quazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00533	0.0161	CbGeAlD
Quazepam—GABRR1—brain—attention deficit hyperactivity disorder	0.00524	0.0158	CbGeAlD
Quazepam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.00524	0.0158	CbGeAlD
Quazepam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.00517	0.165	CrCbGaD
Quazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00515	0.0156	CbGeAlD
Quazepam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00511	0.0154	CbGeAlD
Quazepam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00502	0.16	CrCbGaD
Quazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00496	0.015	CbGeAlD
Quazepam—GABRD—brain—attention deficit hyperactivity disorder	0.00456	0.0138	CbGeAlD
Quazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00451	0.0136	CbGeAlD
Quazepam—GABRG1—brain—attention deficit hyperactivity disorder	0.00439	0.0132	CbGeAlD
Quazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.0043	0.137	CrCbGaD
Quazepam—GABRB1—brain—attention deficit hyperactivity disorder	0.00425	0.0128	CbGeAlD
Quazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.00423	0.0128	CbGeAlD
Quazepam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.0042	0.0127	CbGeAlD
Quazepam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00404	0.0122	CbGeAlD
Quazepam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00395	0.0119	CbGeAlD
Quazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.00394	0.0119	CbGeAlD
Quazepam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00392	0.0118	CbGeAlD
Quazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00384	0.0116	CbGeAlD
Quazepam—GABRE—nervous system—attention deficit hyperactivity disorder	0.0038	0.0115	CbGeAlD
Quazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00371	0.0112	CbGeAlD
Quazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00369	0.0112	CbGeAlD
Quazepam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.00366	0.0111	CbGeAlD
Quazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00361	0.0109	CbGeAlD
Quazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00357	0.0108	CbGeAlD
Quazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00349	0.0105	CbGeAlD
Quazepam—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00337	0.0102	CbGeAlD
Quazepam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00322	0.00974	CbGeAlD
Quazepam—GABRG2—brain—attention deficit hyperactivity disorder	0.00321	0.00969	CbGeAlD
Quazepam—GABRR2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00317	0.00498	CbGpPWpGaD
Quazepam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.0031	0.00937	CbGeAlD
Quazepam—GABRG3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00309	0.00485	CbGpPWpGaD
Quazepam—GABRB1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00304	0.00478	CbGpPWpGaD
Quazepam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00303	0.00916	CbGeAlD
Quazepam—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00297	0.00465	CbGpPWpGaD
Quazepam—GABRR2—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.00295	0.00463	CbGpPWpGaD
Quazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.00293	0.00885	CbGeAlD
Quazepam—GABRE—brain—attention deficit hyperactivity disorder	0.00291	0.00878	CbGeAlD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00284	0.00446	CbGpPWpGaD
Quazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.00283	0.00856	CbGeAlD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00279	0.00438	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00274	0.0043	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00272	0.00427	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00267	0.0042	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00261	0.0041	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00257	0.00404	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00255	0.004	CbGpPWpGaD
Quazepam—GABRA5—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00253	0.00397	CbGpPWpGaD
Quazepam—GABRA3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00248	0.00389	CbGpPWpGaD
Quazepam—GABRB3—brain—attention deficit hyperactivity disorder	0.00247	0.00744	CbGeAlD
Quazepam—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00244	0.00383	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00243	0.00381	CbGpPWpGaD
Quazepam—GABRB3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00242	0.0038	CbGpPWpGaD
Quazepam—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00238	0.00373	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00234	0.00367	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00214	0.00335	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0021	0.00329	CbGpPWpGaD
Quazepam—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00208	0.00326	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00206	0.00323	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00205	0.00321	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00201	0.00315	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.002	0.00314	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00197	0.00309	CbGpPWpGaD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00195	0.00305	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00186	0.00291	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00176	0.00276	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0017	0.00267	CbGpPWpGaD
Quazepam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00165	0.00498	CbGeAlD
Quazepam—GABRA5—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00164	0.00257	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00162	0.00255	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00161	0.00252	CbGpPWpGaD
Quazepam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00159	0.0048	CbGeAlD
Quazepam—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00158	0.00248	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00157	0.00246	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00154	0.00242	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00153	0.0024	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00151	0.00236	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00146	0.0023	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00144	0.00225	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0014	0.00219	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00137	0.00215	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00137	0.00215	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00136	0.00213	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00135	0.00211	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00134	0.0021	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00132	0.00207	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00131	0.00205	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00205	CbGpPWpGaD
Quazepam—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0013	0.00205	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0013	0.00204	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00125	0.00196	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00124	0.00195	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00123	0.00193	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.0019	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00121	0.00189	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0012	0.00188	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00118	0.00185	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00116	0.00182	CbGpPWpGaD
Quazepam—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00116	0.00181	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00115	0.0018	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00113	0.00178	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00113	0.00177	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00112	0.00176	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00111	0.00174	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0011	0.00172	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00109	0.00172	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00108	0.00169	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00107	0.00168	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00107	0.00168	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00107	0.00168	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00106	0.00166	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00106	0.00166	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00105	0.00165	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00164	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00164	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00103	0.00161	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00103	0.00161	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00102	0.00161	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00102	0.00161	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00101	0.00158	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000994	0.00156	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000984	0.00154	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000977	0.00153	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000953	0.00149	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000944	0.00148	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00094	0.00147	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000938	0.00147	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000929	0.00146	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000923	0.00145	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000922	0.00145	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000907	0.00142	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000906	0.00142	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000901	0.00141	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0009	0.00141	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00089	0.0014	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000886	0.00139	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000885	0.00139	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000884	0.00139	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000881	0.00138	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00088	0.00138	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000877	0.00138	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000877	0.00138	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000874	0.00137	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000868	0.00136	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000868	0.00136	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000864	0.00136	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000858	0.00135	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000849	0.00133	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000843	0.00132	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000843	0.00132	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000838	0.00131	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000838	0.00131	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000828	0.0013	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000823	0.00129	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000823	0.00129	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000819	0.00128	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00081	0.00127	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000808	0.00127	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000807	0.00127	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000804	0.00126	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000803	0.00126	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000798	0.00125	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000792	0.00124	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000791	0.00124	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00079	0.00124	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000789	0.00124	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000784	0.00123	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000779	0.00122	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000774	0.00121	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000765	0.0012	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000759	0.00119	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000754	0.00118	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000752	0.00118	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000748	0.00117	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000747	0.00117	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000733	0.00115	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00073	0.00115	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000724	0.00114	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00072	0.00113	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000719	0.00113	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000719	0.00113	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000707	0.00111	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000695	0.00109	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000691	0.00108	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000689	0.00108	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000678	0.00106	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00067	0.00105	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000662	0.00104	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00066	0.00104	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000658	0.00103	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000658	0.00103	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00065	0.00102	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000646	0.00101	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000646	0.00101	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000642	0.00101	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000641	0.00101	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000639	0.001	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000637	0.000999	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000635	0.000996	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000635	0.000996	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000631	0.000989	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00063	0.000989	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000624	0.000978	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000621	0.000974	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000619	0.000971	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000616	0.000967	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000611	0.000959	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000607	0.000952	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000597	0.000936	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000593	0.00093	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000591	0.000927	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000586	0.00092	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000576	0.000904	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000572	0.000898	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000562	0.000882	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000551	0.000865	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000545	0.000855	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000541	0.000849	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000539	0.000845	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000538	0.000844	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000507	0.000796	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000504	0.000791	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0005	0.000784	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000498	0.000782	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000495	0.000776	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000491	0.000771	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00049	0.000768	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000487	0.000763	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000486	0.000763	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000483	0.000758	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000478	0.00075	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000477	0.000748	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000474	0.000744	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000418	0.000655	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000415	0.000651	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000392	0.000616	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000387	0.000607	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000355	0.000557	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000321	0.000503	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000316	0.000496	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000315	0.000494	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000314	0.000492	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000312	0.000489	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00031	0.000486	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000308	0.000483	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000302	0.000474	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000288	0.000452	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000286	0.000449	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000285	0.000447	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000284	0.000446	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000264	0.000414	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00019	0.000298	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000189	0.000296	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000187	0.000294	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000129	0.000203	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000118	0.000185	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.92e-05	0.00014	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	8.92e-05	0.00014	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.78e-05	0.000138	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.16e-05	0.000128	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	8.13e-05	0.000128	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.13e-05	0.000128	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	8e-05	0.000126	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.77e-05	0.000122	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.44e-05	0.000117	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.13e-05	0.000112	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.79e-05	0.000107	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.5e-05	0.000102	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.19e-05	9.71e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.4e-05	8.48e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.37e-05	8.42e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.36e-05	8.42e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.36e-05	8.42e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.28e-05	8.28e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.2e-05	8.16e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.93e-05	7.73e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.91e-05	7.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.89e-05	7.68e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.74e-05	7.44e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.29e-05	6.73e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.08e-05	6.4e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.25e-05	5.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.23e-05	5.06e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.32e-05	3.64e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.11e-05	3.32e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.39e-05	2.19e-05	CbGpPWpGaD
